NEOADJUVANT CHEMOIMMUNOTHERAPY
Clinical trials for NEOADJUVANT CHEMOIMMUNOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT CHEMOIMMUNOTHERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT CHEMOIMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach aims to boost lung cancer treatment in poor responders
Disease control Not yet recruitingThis phase II trial tests a special type of radiation called lattice radiation therapy (LRT) combined with standard chemoimmunotherapy for people with stage III lung cancer that did not shrink enough after initial treatment. The LRT delivers high-dose radiation to specific spots …
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Triple threat: radiation plus Immuno-Chemo shows promise for lung cancer
Disease control Not yet recruitingThis study tests whether adding a special type of radiation (SF-SBRT) to the usual combination of immunotherapy (toripalimab) and chemotherapy helps people with stage II-III non-small cell lung cancer live longer without the cancer coming back. About 200 participants will be rand…
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Phase: PHASE3 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a heart drug boost colon cancer treatment?
Disease control Not yet recruitingThis study tests if adding a common heart medication (propranolol) to standard chemotherapy and immunotherapy before surgery can improve outcomes for people with a certain type of colon cancer. About 45 adults with stage II or III colon cancer that is mismatch repair proficient (…
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Simple bike test could revolutionize lung cancer risk assessment
Knowledge-focused Not yet recruitingThis study will test if a simple, low-intensity cycling exercise combined with a handheld monitor can predict serious complications in lung cancer patients before surgery or other treatments. Researchers will include 500 adults with suspected lung cancer. The goal is to make risk…
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Sponsor: Linkoeping University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC